CASIF · CASI Pharmaceuticals, Inc.
$0.13
+0.00 (+0.93%)
At close · Jul 27
Market Cap
$2.65M
Shares
20.56M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$10,000,000
as of 2021-12-15
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $278,000 | 20-F, filed 2026-05-15 |
| 2022-12-31 | $3,267,000 | 20-F, filed 2025-03-31 |